Follow-on offering Announced
Pyxis Oncology equity raising
US$110m raised
Announced Sep 2026 · NASDAQ: PYXS
Advisers
Pyxis Oncology
Issuer
Not disclosed
Lead managers
- Legal adviser
- Issuer
- Pyxis Oncology
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Oncology
Similar deals
- Remix Therapeutics placement Jun 2026 · US$100m · Biotech
- BlossomHill Therapeutics IPO Aug 2026 · US$150m · Biotech
- Perspective Therapeutics equity raising Feb 2026 · US$175m · Radiopharmaceuticals
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
Sources
- Sep 2026 Latham Advises on Pyxis Oncology Public Offering lw.com
